US Cancer Sex Rule Sparks Concern
Starting in 2026, U.S. cancer registries will be forced to classify patient sex solely as "male," "female," or "unknown," a directive from the Trump administration that has sparked alarm among scientists and transgender rights advocates. This policy shift is expected to severely hinder the understanding of cancer diagnoses and trends within the transgender population, making it more difficult to address critical health disparities for this marginalized group.